AMGN, AQUA, COHU, DEA, HIW, IBB, ISBC, LUMN, ONB, TAK

Economy: 

Private payrolls up 374,000 in August, far short of 600K estimate: ADP

The BLS reported that payroll employment increased by 235K last month and the unemployment rate declined by .2% to 5.2%. The consensus was for a 750,000 increase. The resurging pandemic may partly be the cause of the big estimate misses in both the BLS and ADP numbers. 

The change in total nonfarm payroll employment for June was revised up by 24,000, from +938,000 to +962,000, and the change for July was revised up by 110,000, from +943,000 to +1,053,000. With these revisions, employment in June and July combined is 134,000 higher than previously reported." Employment Situation Summary 

The U-6 rate was reported at 8.8%, down from 9.2% in July.  Table A-15. Alternative measures of labor underutilization 

Total Unemployed, Plus All Persons Marginally Attached to the Labor Force, Plus Total Employed Part Time for Economic Reasons, as a Percent of the Civilian Labor Force Plus All Persons Marginally Attached to the Labor Force (U-6) (U6RATE)-St. Louis Fed

Social Security trusts to run out of money sooner than expected due to Covid There will be a fiscal Day of Reckoning for the U.S., probably occurring before SS starts to run out of money. Debt to the Penny | U.S. Treasury Fiscal Data

Federal Debt: Total Public Debt-St. Louis Fed As shown in the previous chart, the total debt was less than $1T in the 1981 third quarter. 

Euro zone inflation August 2022 at 3% Y-O-Y Germany experienced a 3.4% increase. The ECB benchmark rate is -.50. Key ECB interest rates The German 10 year government bond is below zero. Germany 10 Year Government Bond Overview 

Niall Ferguson: Inflation could repeat the 1960s, when the Fed lost control

+++++

Markets and Market Commentary: 

Here’s why this billionaire investor John Paulson predicts cryptocurrencies will ‘go to zero’ - MarketWatch

European Commission Approves BioMarin’s (BMRN) VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close 

Amazon Partners with Affirm to Deliver Pay-Over-Time Option at Checkout

Regeneron Is More Than a Covid Play. Its Drug Dupixent Will Be a Giant Seller. | Barron's The analyst quoted is from Benchmark who opined that Dupixent may be the world's top selling drug by 2030. REGN discovered this drug but Sanofi books the sales and shares with REGN the profits. REGN SEC Filed Second Quarter Earnings Report at page 17 REGN and "Sanofi equally share profits and losses from sales within the United States. We and Sanofi share profits outside the United States on a sliding scale based on sales starting at 65% (Sanofi)/35% (us) and ending at 55% (Sanofi)/45% (us), and share losses outside the United States at 55% (Sanofi)/45% (us). In addition to profit and loss sharing, we are entitled to receive sales milestone payments from Sanofi. In the third quarter of 2020, the Company earned, and recognized as revenue, the first $50.0 million sales-based milestone from Sanofi, upon aggregate annual sales of antibodies outside the United States (including Praluent) exceeding $1.0 billion on a rolling twelve-month basis. We are entitled to receive up to an aggregate of $200.0 million in additional milestone payments from Sanofi, including the second sales milestone in the amount of $50.0 million, when such sales outside the United States exceed $1.5 billion on a rolling twelve-month basis."  Page 19 REGN 2020 Annual Report I also own SNY. 

Ford's August U.S. sales fall 33% as chip shortage hits auto industry I do not own Ford shares. 

Verizon increases dividend for 15th consecutive year The new quarterly dividend is $.64 per share, up 1.25 cents per share. I own a few VZ shares as a bond substitute. 

I am continuing to reduce my stock allocation. I am likely to eliminate most of my stock ETF positions as part of that ongoing reduction. Those positions are generally less than 10 shares. 

+++

Earnings Reports-Owned Stocks: 

Consolidated Edison (ED) SEC Filed Earnings Press Release (adjusted net income of $182M or $.53 per share with the consensus at $.622 per Fidelity) 

Discovery (DISCA) SEC Filed Press Release (GAAP E.P.S. of $1.01 which included a 9 cent after tax gain from selling Great American Country; consensus at $.86; revenues at $3.062B, up 21% Y-O-Y; free cash flow $757M; as of 8/3/21, DISCA had 18M subscribers to its streaming service; Discovery is no longer trading IMO on its results but on investor perceptions about its acquisition of Warner Media from AT & T which will load the company up with debt. I  eliminated DISCA, but recently bought a few shares back thereafter which I have not discussed here. Item # 1.C. Eliminated DISCA Sold 10 at $42.68  (2/27/21 Post).

Dominion Energy (D) SEC Filed Earnings Press Release (non-GAAP E.P.S. at $.76 with consensus at $.76; guided 3rd quarter to non-GAAP E.P.S. between $95-$1.10; affirmed "its full-year 2021 operating earnings guidance range of $3.70 to $4.00 per share."; revenues = $3.038B). 

Dropbox (DBX) SEC Filed Earnings Press Release (non-GAAP E.P.S. = $.40 with the consensus at $.329 per Fidelity; GAAP E.P.S. at $.22; "net cash provided by operating activities was $219.9 million, as compared to $145.9 million in the same period last year. Free cash flow was $216.0 million, as compared to $119.8 million in the same period last year."; "cash, cash equivalents and short-term investments ended at $1.944 billion."; "revenue was $530.6 million, an increase of 13.5% from the same period last year. On a constant currency basis, year-over-year growth would have been 11.4%")

Enbridge (ENB) SEC Filed Press Release (adjusted earnings of C$1.4 billion or C$0.67 per common share, with the consensus at C$.564; GAAP E.P.S. at C$.69; distributable Cash Flow (DCF) of C$2.5 billion or C$1.24 per common share, compared with C$2.4 billion or C$1.21 per common share in 2020; reaffirmed full year DCF of C$4.7 to C$5 per share) 

Entergy (ETR) SEC Filed Earnings Press Release (adjusted E.P.S. of $1.34 with consensus at $1.405 per Fidelity; affirmed 2021 adjusted E.P.S. guidance of $5.8 to $6.10) 

Evergy (EVRG) SEC Filed Press Release (adjusted net income of $195M or $.85 per share with the consensus at $.729 per Fidelity; "reaffirmed its 2021 adjusted EPS guidance range of $3.20 to $3.40 and long-term adjusted EPS annual growth target of 6% to 8% from 2019 through 2024."; declared quarterly dividend of $.535 per share)

Great Ajax (AJX) SEC Filed Earnings Press Release (diluted E.P.S. of $.42 with the consensus at $.313 per Fidelity; book value per share at $15.86)

Healthcare Trust of America (HTA) SEC Filed Earnings Press Release (FFO at $.44, up 10% compared to the 2020 second quarter; normalized CAD at $81M, up 4.5%, or $.364+ per share; quarterly dividend at $.36 per share; as of 6/30/21 "portfolio had a leased rate of 89.3% by gross leasable area (“GLA”) and an occupancy rate of 87.9% by GLA"; "during the three months ended June 30, 2021, HTA closed on the previously announced disposition of a 13 property portfolio with locations in Tennessee and Virginia, with an aggregate gross sales price of $67.5 million. This transaction qualified as a 1031 exchange with net proceeds held in a restricted cash account at quarter end. This portfolio generated annual returns of 10% over its 13-year period and generated a gain of approximately $32.8 million.")

LyondellBasell (LYB) SEC Filed Earnings Press Release (net income of $2.1B; E.P.S. at $6.13 with the consensus at $5.573 per Fidelity; revenues = $11.561B, up from $5.546B in the 2020 second quarter which is illustrates LYB's cyclical business; generated $1.9B in cash during quarter allowing the company to raise its quarterly dividend and to reduce debt from $13.6B to $12.7B) 

OFS Capital (OFS) SEC Filed Press Release (net investment income of $.24 per share with consensus at $.23 per Fidelity; net asset value per share = $13.42, up from $11.96 as of 3/31/21; no new loans on nonaccrual; weighted average yield on debt investments = 8.91%; Board declared a $.24 per share quarterly dividend)

PennantPark Investment (PNNT) SEC Filed Press Release (core net investment income per share of $.14; GAAP net asset value per share = $9.59, up from $8.78 as of 12/31/20, 10-Q at p. 4; yield on debt investments = 9.2%) 

Rent-A-Center (RCII) SEC Filed Earnings Press Release (non-GAAP E.P.S. = $1.63 with the consensus at $1.353 per Fidelity; revenues of $1.2B: For the six months ended June 30, 2021, the Company generated $250.5 million of cash from operations, and ended the second quarter of 2021 with $145.1 million of cash and cash equivalents, $1.32 billion of debt outstanding, $608 million of liquidity including $463 million of undrawn revolving credit, and a pro-forma net debt to Adjusted EBITDA ratio of 1.7 times.")

Virginia National Bankshares Corporation (VABK) Announces Second Quarter Financial Results And Availability Of Dividend Reinvestment Plan (GAAP E.P.S. of $.03, hit by $5.9M in acquisition related costs; non-GAAP E.P.S. = $.89; no analyst estimates; NIM = 3.05%; loan to deposit ratio = 71.6%; net recoveries; NPA Ratio = .18%; NPL Ratio = zero; Total capital ratio = 13.47%; tangible book value per share = $26.6; other ratios distorted by merger expense) 

++++ 

Madison Cawthron (R-NC) Defends 'Bloodshed' Over 'Rigged' Election Remarks After Fierce Backlash; Rep. Madison Cawthorn (R-NC) promotes false election claims, warns of 'bloodshed' if fraud occurs in future 

Rep. Madison Cawthorn (R-NC) tried to board plane with gun; could face fine

Kevin McCarthy (R-CA) Threatens Firms Not to Help January 6 Probe McCarthy, the House minority leader, made it clear that private companies will pay a price when Republicans regain control for supplying information in response to House subpoenas. 

Opinion | Joe Biden’s Critics Lost Afghanistan - The New York Times

Opinion | Republicans are guilty of mind-boggling hypocrisy in their attacks on Biden’s Afghanistan exit - The Washington Post Being a brazen hypocrite is normal for members of that political tribe. It may be required for admission along with publicly stating belief in an assortment of fact free conspiracy theories. 

Most Americans favor Afghanistan withdrawal, criticize Biden for his handling | Pew Research Center (42% wanted to keep U.S. troops in Afghanistan)

Two church events in Illinois linked to 180 Covid-19 cases, 5 hospitalizations 

Senator Mitch McConnell (R-KY) Won't Do Anything to Ease Vaccine Hesitancy-YouTube

Florida GOP candidate threatens opponent with Russian-Ukrainian 'hit squad' in leaked call: report | TheHill

Republican Steve Lynch Threatens School Board Members-YouTube; A Pennsylvania GOP Candidate Steve Lynch Called for '20 Strong Men' to Remove School Boards That Impose Mask Mandates 

Joe Rogan says he has Covid, took widely discredited horse drug ivermectin It is disheartening that this fool has 13 million followers on Instagram and a large audience for his podcast streamed on Spotify. Joe Rogan, A Podcasting Giant Who Has Been Dismissive of Vaccination, Has Covid - The New York Times; Joe Rogan - Wikipedia 

See the question that made ex-Trump attorney Sidney Powell leave interview - YouTube Facts are of course irrelevant in TrumpWorld where reality creations rule and are treated as facts. 

Trump and Boebert's Oil Spin - FactCheck.org ("The U.S. imported an average of 536,400 barrels of crude oil and petroleum products a day from Persian Gulf countries in the first five months of 2021, according to EIA data. That’s a 30% decline from the monthly average of 767,166 barrels a day that the U.S. imported from those countries in 2020, and a 44% decline in average monthly imports compared with 2019.") Donald claimed that he weaned the U.S. off Mideast oil and that Biden was begging them for more. The truth is that oil imports from the Mideast have continued a long decline under the Biden administration. 

Opinion | Kevin McCarthy emerges as a demagogue in his own right - The Washington Post This opinion column is written by Michael Gerson, a republican and a former George Bush speechwriter. He argues that McCarthy has embraced Trumpism as the predominant governing ideology of the republican party which affirms "the new ideological ecosystem of the American right — its lawless governing theory, its cultlike conspiracy theories and its threat of political violence."  It is also important that Trump's party has adopted lying and demagoguery as the primary ways to interact with voters. 

+++

1. Small Ball-Primarily About Risk Management: 

A. Bought 10 ONB at $15.97: 

Quote: Old National Bancorp (ONB)

Closing Price 9/2/21: ONB $16.60 +$0.15  +0.91% 

ONB is the holding company for One National Bank that operates in Indiana, Kentucky, Michigan, Minnesota and Wisconsin.

ONB Analyst Estimates

SEC Filings

2020 Annual Report 

10-Q for the Q/E 6/30/21

Investment Category: Regional Bank Basket Strategy

Last Elimination: Item # 1.H. Eliminated ONB-Sold 15 at $17.87 (2/13/21 Post) 

Last Buy Discussions: Item # 1.D. Added 5 ONB at $12.23 (10/24/20 Post); Item # 4.B. Restarted ONB-Bought 10 at $12.71  (6/27/20 Post)

Dividend: Quarterly at $.14 per share ($.56 annually)

Old National Bancorp Dividends

Last raised from $.13 effective for the 2020 first quarter payment. 

Yield at $15.97 = 3.51%

Last Ex Dividend Date: 8/31/21 (owned as of)

Last Earnings Report (Q/E 6/30/21): SEC Filed Press Release

GAAP E.P.S. = $.38

Non-GAAP E.P.S. =  $.41

Non-GAAP excludes "pre-tax charges of $6.5 million for the recently announced merger with First Midwest Bancorp and $0.4 million for the ONB Way."

NIM = 2.91%

NPL Ratio: 1.03%

Coverage Ratio = 77%

Net Recoveries of $336K

Total Capital Ratio = 12.73% 

Tangible Book Value per share = $11.55

Adjusted ROTE =  14.56%

Adjusted Efficiency = 57.74% 

Other Sell Discussions: Item # 1 Sold 100 ONB at $13 (8/22/12 Post); Item # 1 Sold 50 ONB at $14.12 (7/16/13 Post); Item # 6 Sold 50 ONB at $13.05-Update For Regional Bank Basket Strategy As Of 6/6/16 - South Gent | Seeking Alpha; Item 2.A. Eliminated ONB-Sold 50 Shares at $18.55 (2/27/17 Post)(largest single gain at $312.97 bought at $12.25); Item # 4.A. Sold 10 ONB at $19.66 (7/29/18)

ONB Realized Gains to Date: $865.78

B. Eliminated ISBC in Vanguard Taxable-Sold 12 at $14.3: 

Quote: Investors Bancorp Inc. (ISBC)

ISBC SEC Filings

I still own 30 shares in my Fidelity taxable account. The average cost per share is $7.48: 

Snapshot 9/2/21 close 

ISBC is in the process of being acquired by Citizens Financial Group, Inc., which I also own. "Under the terms of the agreement and plan of merger, Investors shareholders will receive 0.297 of a share of CFG common stock and $1.46 in cash for each share of Investors they own."

I sold the 12 shares on the ex dividend day.  

Investment Category: Regional Bank Basket Strategy

Profit Snapshot: +$79.59

Last Buy Discussions: Item # 1.G. Bought 5 ISBC at $7.21; 5 at $7.09; 5 at $6.9(10/24/20 Post); Item # 1.D. Started ISBC-Bought 10 at $7.97; 4 at $7.7 (9/5/20 Post)

Last Sell Discussion: Item # 2.E. Sold All ISBC Shares Bought with Dividends at $14.64 (6/19/21 Post) 

C. Bought 10 LUMN at $11.72: 

This is a new name for me. 

Quote: Lumen Technologies Inc 

Closing Price 9/2/21: LUMN $12.35 +$0.22 +1.81% 

LUMN Analyst Estimates | MarketWatch

LUMN SEC Filings 

10-Q for the Q/E 6/30/21 (long term debt at $28.574B with cash at $935M as of 6/30/21)

2020 Annual Report 

Website: Enterprise Technology for the Digital Revolution 

Major Recent Developments-Asset Sales: 

Lumen to sell local incumbent carrier operations in 20 states to Apollo Funds for $7.5 billion (8/3/21)("Lumen will retain its ILEC assets in 16 states, as well as its national fiber routes and CLEC (competitive local exchange carrier) networks"; sale includes approximately $1.4B in debt assumption) 

Lumen to Sell Latin American Business to Stonepeak for $2.7B (7/26/21)

Investment Category: Bond Substitute/Lottery Ticket Basket

Dividend: Quarterly at $.25 (likely to be cut)

Lumen Technologies declares quarterly cash dividend

This Company Might Cut Its Dividend, but Its Stock Could Soar | The Motley Fool Author argues that a dividend cut may help the stock performance as the company invests in higher growth businesses.  

Current Yield at $11.72 TC per share =  8.53% (assumes no dividend cut)

Last Ex Dividend: 8/27/21 (owned as of)

Last Earnings Report (Q/E 6/30/21): 

2021 outlook: 

D. Bought 2 AQUA at $36.45: 

Quote: Evoqua Water Technologies Corp. 

Closing Price 9/2/21: AQUA $39.19  +$0.43 +1.11% 

AQUA "provides a wide range of product brands and advanced water and wastewater treatment systems and technologies, as well as mobile and emergency water supply solutions and service contract options through its branch network. Headquartered in Pittsburgh, Pennsylvania, EWT is a multinational corporation with operations in the United States (“U.S.”), Canada, the United Kingdom (“UK”), the Netherlands, Germany, Australia, the People’s Republic of China, Singapore, the Republic of Korea and India."

Website: Evoqua Water Technologies

Products and Services: Proven solutions for water & wastewater treatment

AQUA Analyst Estimates | MarketWatch

AQUA SEC Filings 

10-Q for the Q/E 6/30/21 

This is a new name for me. 

Investment Category: Lottery Ticket Basket

Dividends: None and none expected 

Last Earnings Report (Q/E 6/30/21): SEC Filed Earnings Press Release 

GAAP E.P.S. = $.11

Non-GAAP E.P.S. = $.17

Consensus at $.185 per Fidelity

Revenues up 6.3% to $369.7M

Adjusted EBITDA = $66.2M, up 3.8%

 Evoqua Water Technologies Corp (AQUA) Q3 2021 Earnings Call Transcript | The Motley Fool

Analyst Responses to Earnings Report (8/4-5/21): I do not have access to these reports.  

Goldman Sachs: Maintains Buy, increases PT to $39 from $36

Raymond James: Maintains Outperform adjusts PT to $37 from $35 

RBC: Maintains Outperform, adjusts PT to $41 from $.38

Baird: Maintains Outperform, adjusts PT to $41 from $32

Citigroup: Maintains Neutral, adjusts PT to $37 from $31  

Stock Prices: The earnings report was released prior to the market's open on 8/3/21. 

Broker Report (available to Schwab customers): 

Credit Suisse (8/3/21) : Outperform with a $38 PT 

E. Added to TAK -Bought 5 at $16.36: 

Quote: Takeda Pharmaceutical Co. Ltd. ADR

1 ADR = .5 ordinary

Ordinary Share Quote: 4502.T Takeda Pharmaceutical Company

1 JPY to USD - Japanese Yen to US Dollars Exchange Rate

Website: Takeda

TAK Analyst Estimates | MarketWatch

SEC Filings-Foreign Company Forms 

SEC Filed Annual Report for the F/Y ending 3/31/21 

Buy Discussions: Item # 3.P. Added to TAK-Bought 5 at $17.12; 5 at $16.13 (6/4/21 Post); Item # 2.H. Bought 10 TAK at $17.22 (5/23/21 Post) 

Current Position: 25 shares 

Average Cost Per Share = $16.93

Purchase Restriction = Each subsequent purchase must be at the lowest price in the chain.

Maximum Position: 100 shares 

Last Earnings Report (Q/E 6/30/21): SEC Filing Results are report in Yen. 

Revenues by Product: 

Recent News: Takeda Updates its Q1 FY2021 Earnings Materials to Reflect Impact of Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie

F. Added 1 AMGN at $229.69: 

Quote: Amgen Inc.

Website: Investors | Amgen Inc.

Amgen Pipeline

AMGN SEC Filings

10-Q for the Q/E 6/30/21 

2020 Annual Report

5 Year Financials: 

Page 58 Annual Report

Last Buy Discussion: Item # 1.I. (1/9/21 Post) I discussed the 2020 3rd quarter earnings report in that post. 

Dividend: Quarterly at $1.76 per share  ($7.04 annually)

Dividend Information | Amgen Inc.

Yield at $229.69 = 3.07%

Last Ex Dividend: 8/16/21 (owned as of)

Last Earnings Report (6/30/21): Amgen (AMGN) Reports Second Quarter 2021 Financial Results

Non-GAAP net income of $2.522B or $4.38 per share with the consensus at $4.091 per Fidelity; 

Total revenue at $6.526B, up 5% Y-O-Y; 

"cumulative decrease in diagnoses over the course of the pandemic has suppressed the volume of new patients starting treatment, which we expect to continue to impact our business during the second half of the year."; 

generated $1.7B in free cash flow; repurchased 6.5M shares of common stock during the quarter at a cost of $1.6B 

Product Sales: 

Enbrel accounted for $1.144B of the $6.114B in total revenues. Enbrel "sales decreased 8% year-over-year for the second quarter, primarily driven by lower net selling price and unfavorable changes in estimated sales deductions. On a year-over-year basis volumes declined 1%. Going forward, we expect net selling price to continue to decline year-over-year."

Tax Dispute with the IRS: 

Broker Reports (available to Schwab customers): 

Morningstar (8/4/21 Post): 2 stars with a FV of $200, lowered from $215 based "largely" on the analyst's opinion that the U.S. will raise the tax rate starting in 2022. Notes that free cash flow runs close to 40% of sales. The company is facing competition in its biologic Neulasta.  

Argus (8/13/21): Buy with at PT of $265, reduced from $275 

S & P (8/4/21): 4 stars with a 12 month PT of $276. The analyst has a favorable view of the pipeline and believes the recently FDA approved Lumakras (sotoasib) in advanced non-small-cell lung carcinoma will have better sales than the consensus forecast.  FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer  

Credit Suisse (4/27/21): Outperform with a $258 PT. 

Other Recent News (7/7/21): Tezepelumab Granted Priority Review By U.S. FDA This is an asthma drug developed in cooperation with AstraZeneca; Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults (6/23/21)(2nd quarter revenues for Aimovig were reported at $82M, down 16% Y-O-Y, with all sales made in the U.S.)   

G. Sold 1 IBB at $169.44: 

In my mind's eye, I substituted the higher yielding AMGN for this ETF.  

Quote: IBB | iShares Nasdaq Biotechnology ETF Overview | MarketWatch

Sponsor's Website: iShares Nasdaq Biotechnology ETF | IBB

Expense Ratio = .46%

Profit Snapshot: +$20.69 

Last Discussed: Item # 2.B. Bought 1 IBB at $148.75 (5/8/21 Post) 

Rated 3 stars by Morningstar

Dividends: Quarterly at a variable rate and viewed as immaterial by me

Yield using last 4 dividend payments and a $169.44 price = .167%

H. Bought 2 COHU at $30.85; 1 at $29-Fidelity Account and 1 at $34; 1 at $33.67-Schwab Account : 

Quote: Cohu Inc. 

Closing Price 9/2/21: COHU $34.97 +$0.39 +1.13% 

"Cohu is a leading supplier of semiconductor test and inspection handlers, micro-electromechanical system (MEMS) test modules, test contactors and thermal subsystems, semiconductor automated test equipment . . . used by global semiconductor and electronics manufacturers and test subcontractors."  

Recent News: Next Generation Inspection & Metrology Platform Selected by Major Semiconductor Manufacturers (8/30/21) 

COHU SEC Filings 

Cohu, Inc. Profile | Reuters

2020 Annual Report

COHU Analyst Estimates | MarketWatch

Home | Cohu 

Investor Relations | Cohu, Inc

Investment Category: Lottery Ticket Basket

The Stock Jocks responded negatively to COHU's forward revenue guidance:  

Closing Price Date of Earnings Press Release: COHU $34.42 -$2.84 -7.62% 

COHU reported better than expected earnings for the second quarter, beating the consensus estimate by 9 cents. However, guidance for the third quarter was negatively received by the Stock Jocks. 

Last Earnings Report (Q/E 6/30/21): SEC Filed Press Release 

Non-GAAP E.P.S. = $.89

Consensus at $.80

GAAP E.P.S. = $1.92 (includes profit from selling PCB test business)

Expects third quarter revenues of $220M to $225M, below the consensus of $237.5 prior to the news release. The sale allowed COHU to accelerate a $100M prepayment of its term loan B debt facility. This business accounted for 8% of 2020 revenues. Page 2 

Cohu Completes Sale of its Printed Circuit Board Test Business ("Cohu received cash proceeds of $125.4 million, subject to further potential post-closing adjustments related to a final determination of closing accounts. Cohu intends to use the net proceeds, after estimated transaction costs and taxes, to repay approximately $100 million of the outstanding principal on its term loan facility.") 

I. Bought 5 HIW at $45.68: 

Quote: Highwoods Properties Inc- an Office REIT, a component in the S & P 400 MidCap Index. 

Closing Price 9/2/21: HIW $46.46 +$0.13  +0.28% 

HIW SEC Filings 

10-Q For the Q/E 6/30/21 

2020 Annual Report 

Company Website: Highwoods

Highwoods Properties Inc Profile | Reuters

Highwoods Properties Inc Key Developments | Reuters

Investment Categories: Equity REIT Common and Preferred Stock Basket Strategy/ Bond Substitute

Recent Material News: Highwoods Closes Acquisition of Office Assets From Preferred Apartment Communities (7/29/21 Press Release)("office buildings in Charlotte and Raleigh, which encompass 1,630,000 square feet in total and are currently 94% occupied, are projected to generate cash net operating income of $38.3 million and GAAP net operating income of $42.8 million in the first four quarters following closing.")

Dividends: Quarterly at $.50 per share, a 4.2% increase from the prior quarter.  

Highwoods Declares Quarterly Dividends

Yield at  $45.68 TC = 4.38%

Last Ex Dividend: 8/13/21 (owned as of) 

Last Earnings Report (Q/E 6/30/21):  

Bond Positions: 

I currently own 5 HIW 3.625% SU bonds maturing on 1/15/23 (snapshots as of 8/27/21)

FINRA Bond Detail

Item # 3.B. Bought 2 HIW 3.625% SU Bond at a TC of 98.633 (6/6/20 Post); Item # 3.B. Bought 2 Highwoods Realty 3.625% SU Bonds Maturing on 1/15/23 at a TC of 99,635 (3/20/19 Post); Item # 4.A. Bought 1 HIW 3.625% SU at a TC of  99.349 (4/5/18 Post) 

So far this year, 2 HIW 3.2% SU bonds have matured: 

Item # 2.B. 

 

J. Started DEA in Vanguard Taxable-Bought 10 at $21.24: 

Quote: Easterly Government Properties Inc.

DEA SEC Filings

2020 Annual Report

10-Q for the Q/E 6/30/21

SEC Filed Earnings Press Release for the Q/E 6/30/21 

Closing Price 9/2/21: DEA $21.77  +$0.18  +0.83% 

Investment Category: Equity REIT Common and Preferred Stock Basket Strategy

I have nothing to add to a recent discussion. Item # 3.E. Pared DEA in Fidelity Taxable-Sold 10 at $22.92 (8/20/21 Post) DEA had a stock offering subsequent to that pare that knocked the price down some. Easterly Government Properties Announces Pricing of Forward Common Stock Offering; Prospectus

Dividend: Quarterly at $.265 ($1.06 annually)

Dividend Yield at $21.24 = 4.99%

Last Ex Dividend: 8/11/21 (before purchase)

K. Added 5 DEA in Fidelity Taxable at $21.26: 

See Item #1.K. above. 

New AC this Account: $20.9

Snapshot Intraday on 8/30/21

Yield at New AC  = 5.07%

I bought back 5 of the shares recently sold at $22.92. 

2. Early Bond Redemptions-Subject to Make Whole Payments: 

I am losing my corporate bond portfolio mostly due to early issuer redemptions. My brain had to be rewired to comprehend why an issuer would make a make whole payment associated with an early redemption when the coupon was already historically low and the penalty payment could be avoided altogether by waiting a short period, which was the case for the Ventas bonds discussed below.  The VTR bond maturing on 6/15/23, for example, could have been redeemed at par value plus accrued and unpaid interest on or after 3/1/23. Prospectus 

A. Ventas 3.25% SU Maturing on 8/15/22: 

Profit Associated with Make Whole Payments = $124.68 or 4.16% of the $3,000 principal amount for 3 VTR short term bonds. 

Make Whole Payment: $28.54-One Bond

Profit Snapshot: +$45.47 (1 Bond)

B. Ventas 3.125% SU Maturing on 6/15/23:

Make Whole Payment: +$96.14 (2 bonds)

Profit Snapshot: $113 (2 Bonds) 

I am losing my corporate bonds most every week, mostly to early issuer redemptions.  

The largest corporate bond interest payment received on 9/1/21 was $172.5 for 10 bonds issued by  Virginia Electric maturing on 9/1/22: 

In March 2020, this bond, rated A2 by Moody's, quickly fell in price from about 105 to 97. Item # 5.A. Bought 10 Virginia Electric 3.45% SU Bonds Maturing on 9/1/22 at a TC of 98.826 (total cost includes a $10 brokerage commission or $1 per bond). I bought those bonds on 3/24/20. Virginia Electric has the optional right to redeem prior to 6/1/22 subject to a make whole payment. The company can redeem on or after 6/1/22 at par plus accrued and unpaid interest, so I will lose this bond no later than 6/1/22. Prospectus at p. S-6 

3. Tennessee Municipal Bond Interest Payments 9/1/21: 

Since most of my corporate bonds have either matured or redeemed early mostly subject to make whole payments, Tennessee municipal bonds are my primary source of interest income. These bonds are generally call protected for 10 years after issuance. The optional right to redeem has to wait for that call protection period to expire.  These bonds are sold in 5 bond lots ($1K par value per bond), unlike the corporates where the minimum amount is generally either 1 or 2 bond lots. 

All of the bonds referenced below are 5 bond lots. I own Tennessee Municipal bonds in 3 of my taxable accounts.  

Fidelity: $390.63 

The 3.25% Harpeth Valley Utility bond is rated AA+ by S & P. Only $1.75M in principal amount is outstanding. Emma Page Once bought, it would be difficult to sell. The last trade occurred on 5/1/21 at a 111.207 price to the buyer. 

I bought this bond on 3/23/20 at a total cost of $90.07 (which has embedded a $5 commission). I would have bought up to 20 at that price but only 5 bonds were available from this seller. Item # 6.A. (3/28/20 Post) The bond is not callable until 9/1/2025. 

Most likely, the seller was forced to sell the bonds due to a margin call, or had panicked given the rapid bear market decline that started in February 2020, with the S & P 500 closing at 2,237.50 on 3/23/20, the lowest close during that period.   

Schwab: $175

The 4% Harpeth Valley Utility bond matures in 2040 but will be called on 9/1/22. Item # 1.E. 

Vanguard: $225

 

Disclaimer: I am not a financial advisor, but simply an individual investor who has been managing my own money since I was a teenager. In this post, I am acting solely as a financial journalist focusing on my own investments. The information contained in this post is not intended to be a complete description or summary of all available data relevant to making an investment decision. Instead, I am merely expressing some of the reasons underlying the purchase or sale of securities. Nothing in this post is intended to constitute investment or legal advice or a recommendation to buy or to sell. All investors need to perform their own due diligence before making any financial decision which requires at a minimum reading original source material available at the SEC and elsewhere. A failure to perform due diligence only increases what I call "error creep". Stocks, Bonds & Politics: ERROR CREEP and the INVESTING PROCESS Each investor needs to assess a potential investment taking into account their personal risk tolerances, goals, and situational risks. I can only make that kind of assessment for myself and my family members.